Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone

Journal of Clinical Oncology

Volumn 17, Issue 6, 1999, Pages 1654-1663

  Osoba, David ^a   Tannock, Ian F ^a   Scott Ernst, D ^a   Neville, Alan J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MITOXANTRONE; PREDNISONE;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HORMONE RESISTANCE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PAIN; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0033003176     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.6.1654     Document Type: Article

References (14)

1. Tannock IF, Osoba D, Stockler MR, et al: Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points. J Clin Oncol 14:1756-1764, 1996
2. Stockler MR, Osoba D, Goodwin P, et al: Responsiveness to change in health-related quality of life: A comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales of the EORTC QLQ-C30 and a trial specific module. J Clin Epidemiol 51:37-45, 1998
3. Melzack R: The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1:277-299, 1981
4. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international trials in oncology. J Natl Cancer Inst 85:365-376, 1993
5. Osoba D, Zee B, Pater J, et al: Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 3:353-364, 1994
6. Morrison DF: Multivariate Statistical Methods (ed 2). New York, NY, McGraw-Hill, 1976
7. Hays RD, Hayashi T, Carson S, et al: User's Guide for the Multitrait Analysis Program (MAP). Santa Monica, CA, Rand Corporation, 1988
8. Fayers P, Aaronson N, Bjordal K, et al: EORTC QLQ-C30 Scoring Manual. Brussels, Belgium, Quality of Life Unit, EORTC Data Centre, 1995
9. Osoba D, Rodrigues G, Myles J, et al: Interpreting the significance of health-related quality-of-life scores. J Clin Oncol 16:139-144, 1998
10. King MT: The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 5:555-567, 1996
11. Little R, Yau L: Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics 52:1324-1333, 1996
12. Fairclough DL: Multiple imputation for missing data in longitudinal studies of quality of life. Qual Life Res 6:642, 1997 (abstr)
13. Zee B, Pater J: Statistical analysis of trials assessing quality of life, in Osoba D (ed): Effects of Cancer on Quality of Life. Boca Raton, FL, CRC Press, 1991, pp 113-124
14. Dawson NA: Apples and oranges: Building a concensus for standardized eligibility criteria and end points in prostate cancer clinical trials. J Clin Oncol 16:3398-3405, 1998